The MEDICRIME Committee:

1. monitors the implementation of the Convention by the Parties in particular and, where appropriate:

a. by making proposals to facilitate or improve the effective use and implementation of the Convention, including the identification of any problems and the effects of any declaration or reservation made under the Convention;

b. by expressing an opinion on any question concerning the application of the Convention;

c. by making specific recommendations to Parties concerning the implementation of the Convention.

2. facilitates the collection, analysis and exchange of information, experience and good practice between States to improve their capacity to prevent and combat the counterfeiting of medical products and similar crimes involving threats to public health. Where appropriate, the MEDICRIME Committee shall:

a. facilitate the exchange of information on significant legal, policy or technological developments;

b. express an opinion on any question concerning the application of the Convention.

Focus 2024-2025

Responding to the evolving nature of counterfeit/falsified medical products and other similar crimes involving threats to public health in Europe and beyond, the Council of Europe´s MEDICRIME Committee adopted a MEDICRIME strategy for 2024-2025 which offers new tools and concrete responses to continuous and emerging challenges faced by state authorities.

The strategy aims at strengthening efforts in Europe and beyond by addressing not only the phenomenon of counterfeit/falsified medical products but also its root causes and their promotion, particularly on online media. 

The new strategy will be implemented by the MEDICRIME Committee, in close co-operation and co-ordination with other relevant international organisations and Council of Europe bodies.

Civil society involvement 

• Participant: Conference of INGOs (CINGO)
• Observers
• Consultation with civil society, either through direct participation in meetings, or through dedicated hearings or written consultations